IRONWOOD PHARMACEUTICALS INC Income Tax Expense (Benefit) in USD from Q3 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Ironwood Pharmaceuticals Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2010 to Q3 2025.
  • Ironwood Pharmaceuticals Inc Income Tax Expense (Benefit) for the quarter ending September 30, 2025 was $27.9M, a 104% increase year-over-year.
  • Ironwood Pharmaceuticals Inc Income Tax Expense (Benefit) for the twelve months ending September 30, 2025 was $65M, a 12.9% decline year-over-year.
  • Ironwood Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2024 was $64.3M, a 23% decline from 2023.
  • Ironwood Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2023 was $83.5M, a 7.93% increase from 2022.
  • Ironwood Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2022 was $77.4M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)

IRONWOOD PHARMACEUTICALS INC Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $65M $27.9M +$14.2M +104% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-10
Q2 2025 $50.8M $14.2M -$5.51M -27.9% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-11
Q1 2025 $56.3M $1.11M -$8.01M -87.8% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-12
Q4 2024 $64.3M $21.7M -$10.4M -32.3% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-31
Q3 2024 $74.7M $13.7M -$4.26M -23.7% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-10
Q2 2024 $78.9M $19.7M +$6.48M +48.9% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-11
Q1 2024 $72.5M $9.12M -$11M -54.7% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-12
Q4 2023 $83.5M $32.1M +$8.71M +37.2% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-31
Q3 2023 $74.8M $18M -$1.61M -8.21% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $76.4M $13.3M -$3.45M -20.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $79.8M $20.1M +$2.48M +14.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $77.4M $23.4M +$18.5M +379% Oct 1, 2022 Dec 31, 2022 10-K 2025-03-31
Q3 2022 $58.8M $19.6M +$15.8M +412% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $43.1M $16.7M +$354M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$311M $17.7M +$17.2M +3989% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$328M $4.88M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-16
Q3 2021 $3.83M +$2.44M +176% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$337M -$337M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $432K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 $1.39M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q3 2011 $3K* +$2.95M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q3 2010 -$2.94M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09

IRONWOOD PHARMACEUTICALS INC Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $64.3M -$19.2M -23% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 $83.5M +$6.13M +7.93% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 $77.4M +$405M Jan 1, 2022 Dec 31, 2022 10-K 2025-03-31
2021 -$328M -$330M -12308% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-16
2020 $2.69M +$2.69M Jan 1, 2020 Dec 31, 2020 10-K 2023-02-16
2019 $0 $0 Jan 1, 2019 Dec 31, 2019 10-K 2021-02-17
2018 $0 $0 Jan 1, 2018 Dec 31, 2018 10-K 2021-02-17
2017 $0 $0 Jan 1, 2017 Dec 31, 2017 10-K 2020-02-13
2016 $0 $0 Jan 1, 2016 Dec 31, 2016 10-K 2019-02-25
2015 $0 $0 Jan 1, 2015 Dec 31, 2015 10-K 2018-02-22
2014 $0 Jan 1, 2014 Dec 31, 2014 10-K 2017-02-22
2011 $3K* +$2.95M Jan 1, 2011 Dec 31, 2011 10-K 2014-02-07
2010 -$2.94M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.